[1]Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 [J]. Circ Res, 2000, 87(5):E1-E9.[2]Kim MA, Yang D, Kida K, et al. Effects of ACE2 inhibition in the post-myocardial infarction heart [J]. J Card Fail, 2010, 16(9):777-785.[3]Santos RA, Ferreira AJ, Sinoes E, et al. Recent advances in the angiotensin- converting enzyme 2-angiotensin (1-7)-Mas axis [J]. Exp Physiol, 2008, 93(5):519-527.[4]Mercure C, Yogi A, Callera GE, et al. Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart [J]. Circ Res, 2008, 103(11):1319-1326.[5]曾武涛, 冷秀玉, 王礼春, 等. 血管紧张素(1~7)对兔急性心肌梗死再灌注微血管内皮功能及完整性的保护作用[J]. 中山大学学报: 医学科学版, 2008, 29(3):278- 282.[6]Crackower MA, Sarao R, Oudit GY, et al. Angiotensin -converting enzyme 2 is an essential regulator of heart function [J]. Nature, 2002, 417(6891):822-828.[7]Mercure C, Yogi A, Callera GE, et al. Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart [J].Circ Res, 2008, 103(11):1319-1326.[8]Keidar S, Gamliel-Lazarovich A, Kaplan M, et al. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 acticity in congestive heart failure patients [J]. Circ Res, 2005, 97(9):946-953.[9]Keidar S, Strizevsky A, Raz A, et al. ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects [J]. Nephrol Dial Transplant, 2007, 22(2):597-601.[10]Ishiyama Y, Gallagher PE, Averill DB, et al. Upregulation of angiotensin- converting enzyme 2 after myocardial infarction by blockade of angiotensin Ⅱ receptors [J]. Hypertension, 2004, 43(5):970-976.[11]翁智远, 晋学庆, 吴可贵, 等. 苯那普利、缬沙坦对自发性高血压大鼠肾脏血管紧张素转化酶2表达的影响[J]. 高血压杂志, 2006, 14(5):364-369.[12]Sugimoto K, Qi NR, Kazodova L, et al. Telmisartan but not valsartan increase caloric expenditure and protects against weight gain and hepatic steatosis [J]. Hypertension, 2006, 47(5):1003-1009. |